Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer

JACC: CardioOncology（2022）

引用 8|浏览8

暂无评分

摘要

Patients with active cancer had similar risks for CVA, ICH, and GIB when treated with DOACs compared with warfarin for NVAF.

查看译文

关键词

bleeding,cancer,DOAC,nonvalvular atrial fibrillation,stroke,vitamin K antagonist,warfarin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要